GSK plc (NYSE:GSK) is one of the best cheap stocks under $50 to buy now. On July 15, BofA analyst Sachin Jain maintained a ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine segment. See why the stock is a Buy.

The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...

UK-based Pharma giant GSK plc reported its Q2 earnings earlier today. GSK plc exceeded Q2 2024 expectations with revenue up 13%, operating profit up 18%, and EPS up 17%. GSK upgraded full-year ...

Why GSK Stock Rocketed Nearly 6% ... a performance that easily eclipsed the 0.7% rise of the ... our expert team of analysts issues a “Double Down” stock recommendation for companies that they ...

In May, biotech iTeos Therapeutics decided to close down after being abandoned by GSK over the disappointing mid-stage ...

GSK (GSK) ended the recent trading session at $39.53, demonstrating a -0.38% swing from the preceding day's closing price. The stock fell short of the S&P 500, which registered a gain of 0.22% for ...

We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other healthcare stocks ...

GSK and S&P 500 Performance During 2007-08 Crisis. GSK stock declined from $53 in September 2007 (pre-crisis peak) to around $28 in March 2009, as the markets bottomed out, implying it lost 48% of ...